Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Telomerase expression extends lifespan of normal human cells without oncogenic transformation

Jan. 4, 1999

Modified TAPET organisms with tumor-targeting properties but reduced virulence and side effects

Dec. 30, 1998

Acquisition broadens Isis's antisense patent estate

Dec. 29, 1998

Biodiversity-related grant awarded to Xenova Discovery

Dec. 29, 1998

U.S. patent issued for primate embryonic stem cells; Geron holds license

Dec. 28, 1998

Four-year drug target collaboration signed by PPD and RPR

Dec. 28, 1998

Allelix and Lilly extend drug discovery alliance focusing on several therapeutic areas

Dec. 23, 1998

AxyS and Rhone-Poulenc Rorer enter collaborative agreement

Dec. 21, 1998

Gene discovery collaboration between Bayer and Myriad extended for two more years

Dec. 18, 1998

ArQule enters collaboration with R.W. Johnson for discovery of novel pharmaceuticals

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...